Seven members of a CDC team fell ill while investigating the impact of the train derailment in East Palestine, Ohio, in today's bite-sized hospital and health industry news from Georgia and Ohio.
- Georgia: In February, CDC and FDA issued alerts advising people to stop using several brands of artificial tear drops, including EzriCare Artificial Tears, following reports of an outbreak of a drug-resistant strain of Pseudomonas aeruginosa bacteria. Typically, CDC sees around 150 cases of a similar bacteria every year, mostly in ICU settings. According to Maroya Walters, lead investigator for CDC's antimicrobial resistance team, the spread of this strain "really could change the outlook for that." The bacteria exhibited signs of spreading among asymptomatic patients within a Connecticut facility. This kind of spread typically occurs when patients touch common surfaces or when healthcare workers transmit the germs. Vicente Diaz, the chief of ophthalmology at Yale Health Plan who specializes in infectious diseases, said the infections evading the "big gun" antibiotics was alarming to experts. Ultimately, Diaz expressed concern that if doctors use ineffective antibiotics for too long or wait to culture a bacteria, "that gives the bacteria more time to multiply and get more aggressive." (Jewett/Jacobs, New York Times, 4/3)
- Ohio: CDC on Friday announced that members of a team studying the impact of the train derailment in East Palestine fell ill last month. According to a CDC spokesperson, seven of the 15 CDC investigators reported symptoms similar to those reported by residents following the derailment in early February, including sore throat, headache, coughing, and nausea. For the investigation, CDC's team was taking a house-to-house survey of residents living near the site. While it is still unclear whether their symptoms were caused by exposure to chemicals or fatigue, an official familiar with the cases said the workers were suspicious that they fell ill at the same time with the same symptoms, CNN reports. CDC's spokesperson noted that most team members' symptoms resolved quickly, and all workers were able to continue their work within 24 hours. In addition, none of the affected members have reported any lingering health issues. (Gans, The Hill, 3/31)